Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Stel, Vianda S
Waldum-Grevbo, Bård E
Heaf, James G
de Meester, Johan
García-Marcos, Sergio A
Ambühl, Patrice M
Traynor, Jamie P
Massy, Ziad A
Jager, Kitty J
MetadataShow full item record
CitationBoenink R, Stel VS, Waldum-Grevbo BE, Collart F, Kerschbaum J, Heaf JG, et al. Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy. Kidney international. 2020;98(4):999-1008.doi:10.1016/j.kint.2020.05.039.
AbstractThe objective of this study was to investigate whether the improvement in survival seen in patients on kidney replacement therapy reflects the enhanced survival of the general population. Patient and general population statistics were obtained from the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry and the World Health Organization databases, respectively. Relative survival models were composed to examine trends over time in all-cause and cause-specific excess mortality, stratified by age and modality of kidney replacement therapy, and adjusted for sex, primary kidney disease and country. In total, 280,075 adult patients started kidney replacement therapy between 2002 and 2015. The excess mortality risk in these patients decreased by 16% per five years (relative excess mortality risk (RER) 0.84; 95% confidence interval 0.83-0.84). This reflected a 14% risk reduction in dialysis patients (RER 0.86; 0.85-0.86), and a 16% increase in kidney transplant recipients (RER 1.16; 1.07-1.26). Patients on dialysis showed a decrease in excess mortality risk of 28% per five years for atheromatous cardiovascular disease as the cause of death (RER 0.72; 0.70-0.74), 10% for non-atheromatous cardiovascular disease (RER 0.90; 0.88-0.92) and 10% for infections (RER 0.90; 0.87-0.92). Kidney transplant recipients showed stable excess mortality risks for most causes of death, although it did worsen in some subgroups. Thus, the increase in survival in patients on kidney replacement therapy is not only due to enhanced survival in the general population, but also due to improved survival in the patient population, primarily in dialysis patients. Keywords: dialysis; excess mortality; kidney replacement therapy (KRT); kidney transplantation;
DescriptionTo access publisher's full text version of this article click on the hyperlink below
RightsCopyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
- Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.
- Authors: Vogelzang JL, van Stralen KJ, Noordzij M, Diez JA, Carrero JJ, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ
- Issue date: 2015 Jun
- [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
- Authors: Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N
- Issue date: 2009 Nov-Dec
- Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
- Authors: Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ
- Issue date: 2015 Oct
- Cardiovascular and noncardiovascular mortality among patients starting dialysis.
- Authors: de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW
- Issue date: 2009 Oct 28
- Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
- Authors: Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V
- Issue date: 2019 Feb